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Abstract 
 While selective serotonin reuptake inhibitors (SSRIs) are widely used to treat 
anxiety and depression, they also produce profound disruptions of sexual function 
including delayed orgasm/ejaculation.  The nucleus paragigantocellularis (nPGi), a 
primary source of inhibition of ejaculation in male rats, contains receptors for serotonin 
(5-HT).  The ventrolateral periaqueductal gray (vlPAG) provides serotonin to this region, 
thus providing an anatomical and neurochemical basis for serotonergic regulation of the 
nPGi.  We hypothesize that 5-HT acting at the nPGi could underlie the SSRI-induced 
inhibition of ejaculation in rodents.  To this end, we produced 5-HT lesions of the source 
of 5-HT to the nPGi (the vlPAG) and examined sexual behavior.  Removing the source 
of 5-HT to the nPGi facilitated genital reflexes, but not other aspects of sexual behavior, 
consistent with our hypothesis.  Namely, 5-HT lesions produced a significant increase in 
the mean number of ejaculations and a significant decrease in ejaculation latency as 
compared to sham lesioned animals, while latency to mating and the post-ejaculatory 
interval did not differ.  These data suggest that the serotonergic vlPAG-nPGi pathway is 
an important regulatory mechanism for the inhibition of ejaculation in rats, and supports 
the hypothesis that this circuit contributes to SSRI-induced inhibition of ejaculation. 
 
Keywords:  genital reflexes, ejaculation, copulation, periaqueductal gray, SSRI
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1 Introduction 
 Selective serotonin reuptake inhibitors (SSRIs) are the most commonly 
prescribed class of drugs for individuals with the clinical diagnosis of depression (Arroll 
et al., 2009; Koenig and Thase, 2009).  SSRIs increase synaptic availability of serotonin 
(5-HT) by blocking reuptake at axon terminals (Hiemke and Hartter, 2000; Richelson, 
1994).  A well-documented side effect of SSRI treatment is sexual dysfunction 
(Kennedy and Rizvi, 2009; Schweitzer et al., 2009), with symptoms of decreased libido, 
premature ejaculation, delayed ejaculation, and anorgasmia most commonly reported. 
 The interaction between 5-HT and the neural circuitry underlying mammalian 
sexual behavior is not completely understood, although experiments in the male rat 
have suggested that serotonin can either inhibit or facilitate sexual behavior, depending 
on the brain site in question and/or the type of receptor targeted (Bitran and Hull, 1987; 
de Jong et al., 2006).  For example, systemic administration of 5-HT or 5-
hydroxytryptophan (a precursor to 5-HT synthesis) to male rats increases latency to 
ejaculation (Ahlenius and Larsson, 1991; Gonzales et al., 1982), whereas the 5-HT 
synthesis inhibitor p-chlorophenylalanine decreases ejaculation latency (McIntosh and 
Barfield, 1984).  In addition, general increases in 5-HT levels through chronic systemic 
administration of an SSRI produce delayed ejaculation in male rats (Ahlenius et al., 
1980; de Jong et al., 2005; Mos et al., 1999; Vega Matuszcyk et al., 1998) much like in 
humans (Hsu and Shen, 1995).  In these studies, 5-HT was administered or 
manipulated systematically; therefore the specific brain region(s) mediating the effects 
of 5-HT on sexual behavior are not known.   
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 The nucleus paragigantocellularis (nPGi) of the rostroventrolateral medulla in 
rats, and the homologous structure in humans, the nucleus paragigantocellularis 
lateralis (Zec and Kinney, 2001), is the hypothesized site of descending inhibition of 
genital reflexes in both rats (Marson and McKenna, 1990) and humans (Johnson, 
2006).  The nPGi receives projections from upstream sites related to sexual behavior, 
including the paraventricular nucleus of the hypothalamus, medial preoptic area, and 
periaqueductal gray (Murphy and Hoffman, 2001; Murphy et al., 1999; Normandin and 
Murphy, 2008), and in turn, projects to the spinal motoneurons (pudendal motoneurons) 
innervating the bulbospongiosus and ischiocavernosus muscles (Hermann et al., 2003; 
Marson and Carson 3rd, 1999; Marson and McKenna, 1996; Tang et al., 1999), which 
are critical for ejaculation in male rats (Miura et al., 2001; Pescatori et al., 1993) and 
humans (Hsu et al., 2004; Shafik et al., 2009). 
 The rat nPGi and the human homologue contain 5-HT immunoreactive cells 
(Azmitia and Gannon, 1986; Marson and McKenna, 1992) and application of 5-HT to 
the spinal targets of the nPGi in male rats blocks the urethrogenital reflex (Marson and 
McKenna, 1992).  Similarly, Clément, et al. (2007) found that in male rats, systemic 
administration of the SSRI dapoxetine reduced fictive ejaculatory reflexes, which was 
reversed by lesions of the nPGi.  In addition, lesions of the nPGi in male rats block the 
inhibitory effects of systemic fluoxetine (an SSRI) on sexual behavior (Yells et al., 
1994).  These studies make it clear that 5-HT acts at the level of the spinal cord to 
inhibit genital reflexes, and that 5-HT from the nPGi is a necessary antecedent for 
normal inhibition of genital reflexes.  It is unclear, however, whether 5-HT may also be 
acting at the level of the nPGi to produce the observed effects. 
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 The nPGi, contains receptors for 5-HT including the 5-HT1A (Thor et al., 1992, 
1990), 5-HT1C (Hoffman and Mezey, 1989), 5-HT2A (Fay and Kubin, 2000; Fonseca et 
al., 2001), 5-HT2C (Fonseca et al., 2001), and 5-HT3 (Fonseca et al., 2001) subtypes, 
although only the 5-HT1A and 5-HT2C subtypes are found in abundance (Fonseca et al., 
2001; Thor et al., 1990).  The primary source of 5-HT to the nPGi is the ventrolateral 
periaqueductal gray (vlPAG).  vlPAG neurons project directly to the nPGi (Murphy and 
Hoffman, 2001; Normandin and Murphy, 2008), and these vlPAG-nPGi cells co-localize 
with 5-HT (Bago et al., 2002) and sexual behavior-induced Fos (Normandin and 
Murphy, 2008), suggesting a role for the serotonergic vlPAG-nPGi pathway in male 
sexual behavior.   
 The present studies were designed to test the hypothesis that the effects of 
SSRIs on male sexual behavior are mediated, at least in part, via the nPGi.  Our 
working hypothesis is that removal of the source of 5-HT to the nPGi would alter the 
expression of genital reflexes but not other aspects of sexual behavior. 
 
2 Methods 
 2.1 Subjects 
 Thirty male Sprague-Dawley Rats (Rattus Norvegicus; Charles River; 275-375g) 
were same-sex double-housed in a temperature-controlled vivarium in reverse light 
(lights on 7:00pm, off 7:00am) with ad libitum access to food and water.  All experiments 
were approved by the Georgia State Institutional Animal Care and Use Committee, with 
pain and suffering minimized in accordance with the Committee’s policies. 
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 2.2 Ovariectomy and gonadal-steroid replacement in stimulus females 
 To induce sexual receptivity, ovariectomized female rats were injected with β-
estradiol-3-benzoate (10ug/0.1ml sesame oil s.c.; Sigma Aldrich) 48 hours before 
testing and progesterone (500ug/0.1ml sesame oil s.c.; Fluka) 4 hours before testing as 
previously described (Barfield and Lisk, 1970; McEwen et al., 1987; Normandin and 
Murphy, 2010; Quadagno et al., 1972). 
 2.3 vlPAG 5-HT lesions 
 All surgeries were performed under aseptic conditions.  Male rats (n=30) were 
anesthetized by inhalation of isoflurane (2-5%; Henry Schein) and placed in a 
stereotaxic frame.  The skull was leveled such that bregma and lambda were at the 
same dorsoventral plane, and a craniotomy was performed dorsal to the PAG. vlPAG 
serotonergic-specific lesions were produced by bilateral injection of 5,7-
dihydroxytryptamine creatine sulfate (5,7-DHT; 3mg/ml in 0.9% saline 0.1% ascorbic 
acid; Fluka; n=22 males) using a 1µl Hamilton syringe.  Sham animals received 
equivolume injections of vehicle (0.9% saline 0.1% ascorbic acid; n=8 males). Thirty 
minutes prior to 5,7-DHT administration, all animals received an injection of desipramine 
hydrochloride (25mg/kg in 0.9% Saline i.p.; Sigma) to block uptake of the 5-HT 
neurotoxin by noradrenergic transporters on noradrenergic cells (Bjorklund et al., 1975).  
The coordinates for the vlPAG were (in mm): AP-8.5 bregma, ML +/-0.75, DV-5.75.  5,7-
DHT or vehicle (300nl/side) was slowly injected over 2 minutes and the syringe was left 
in place for 10 min. before being removed.  A small amount of bone wax was placed in 
the burr-hole and the animals’ skin was wound-clipped.  Animals received 
buprenorphine (0.1mg/kg s.c.; Henry Schein) for pain relief and baytril (5mg/kg i.m.; 
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Henry Schein) as a prophylactic antibiotic.  Animals recovered in clean heated cages 
before being returned to the housing facility.   
 2.4 Sexual behavior tests 
 Sexual behavior tests were conducted in acrylic aquariums (61cm x 30.5cm x 
30.5cm).  Animals were acclimated to the arena prior to the initiation of the experiment 
for 10 min. on two consecutive days.   Three and six days later, males engaged in 1-
hour mating bouts with stimulus females to gain sexual experience.  A third mating bout 
on day nine served as the baseline (pre-lesion) measure.  Experimental animals then 
underwent lesion (or sham lesion) surgery as described above.  Following a seven-day 
recovery, a final 1-hour mating bout served as the post-lesion measure.  All sexual 
behavior bouts were recorded and the number of mounts (attempted intromissions 
without the stereotyped pelvic thrust associated with an intromission), intromissions, 
and ejaculations, as well as the latency to begin mating (from placement of female into 
mating chamber to first mount or intromission), ejaculation latency, and post-ejaculatory 
interval was scored.  Data were tabulated for each ejaculatory series and then 
compared across series. 
 2.5 Perfusion / fixation / tissue preparation 
 Following a euthanizing dose of SleepAway (0.5ml i.p.; Henry Schein), all 
animals were transcardially perfused with 250 ml of 0.9% sodium chloride/2% sodium 
nitrite, followed by 300 ml of 4% paraformaldehyde 2.5% acrolein (Polysciences) in 0.1 
M phosphate buffer then 150ml of the sodium chloride/sodium nitrite solution.  Following 
perfusion/fixation, brains were removed and stored at 4°C in 30% sucrose solution until 
sectioned. Brains were cut into 25µm coronal sections in a 1:4 series through the PAG 
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with a Leica 2000R freezing microtome and stored free-floating in cryoprotectant-
antifreeze solution (Watson et al., 1986) at -20°C. 
 2.6 Immunohistochemistry 
 Midbrain tissue sectioned at 25µm in a 1:4 series was processed for NeuN or 5-
HTP for lesion verification as previously described (Loyd and Murphy, 2006; Murphy 
and Hoffman, 2001). Briefly, sections were removed from the cryoprotectant solution, 
rinsed extensively in potassium phosphate buffered saline (KPBS; pH 7.4), and then 
reacted for 20 minutes in 1% sodium borohydride to remove excess aldehydes.  
Sections were then incubated in primary antibody solution directed against either NeuN 
(Millipore, MAB377; monoclonal, raised in mouse; 1:70,000) or 5-HTP (Immunostar, 
24446; polyclonal, raised in rabbit; 1:1,000) in KPBS containing 0.1% Triton-X for 1 hour 
at room temperature followed by 48 hours at 4°C.  After primary antibody incubation, 
tissue was rinsed in KPBS, incubated for 1 hour in biotinylated goat-anti mouse (mouse 
anti-NeuN primary antibody) or goat anti-rabbit (rabbit anti-5-HTP primary antibody) IgG 
(Jackson Immunoresearch) at a concentration of 1:600, rinsed in KPBS, followed by a 
1-hour incubation in avidin-biotin peroxidase complex (Vector Labs, ABC Elite Kit PK-
6100) at a concentration of 1:10. After rinsing in KPBS and sodium acetate (0.175 M; 
pH 6.5), NeuN and 5-HTP were visualized as a black reaction product using nickel 
sulfate intensified 3,3’-diaminobenzidine solution containing 0.08% hydrogen peroxide 
in sodium acetate buffer. The reaction product was terminated after approximately 15 
minutes by rinsing in sodium acetate buffer.  Sections were mounted out of saline onto 
gelatin-subbed slides, air dried overnight, dehydrated in a series of graded alcohols, 
cleared in Histoclear, and cover-slipped using Permount. 
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 2.7 Lesion analysis 
 5,7-DHT lesion and vehicle sham lesion sites were verified by light-microscopic 
analysis of vlPAG-containing brain sections immunohistochemically stained for NeuN or 
5-HTP.  The position of the bottom of the injection track was noted in the NeuN stained 
sections, and the absence or presence of 5-HTP was noted in 5-HTP stained sections.  
Only those injections centered in the vlPAG and with an absence of 5-HTP 
immunoreactivity in the vlPAG were considered for analysis.   
 2.8 Statistical analysis 
 Planned comparisons of mean sexual behavior within the lesion or sham groups 
were analyzed with two-tailed paired t-tests.  Between group (lesion vs. sham) 
comparisons of means of sexual behavior were conducted using independent sample t-
tests (two-tailed).  All statistical comparisons were made with the alpha value set at 
0.05.   
 
3 Results 
 3.1 Lesion Verification 
 An example of 5-HTP immunoreactivity in a lesioned animal and sham-lesioned 
animal is provided in Figure 1.  Serotonergic lesions were restricted to the vlPAG in the 
lesion (n=9) group, with slight spread to the dorsal raphe nucleus, and encompassing 
an approximate 1mm3 volume.  Syringe paths in our sham-lesion group (n=7) ended 
just dorsal to, or within the vlPAG.   The two animals with misplaced lesions (dorsal to 
the vlPAG) did not exhibit any obvious sexual behavior changes.  In addition, no 
obvious changes in non-sexual behaviors were noted in any group. 
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 3.2 Sexual Behavior 
 Serotonergic lesions of the vlPAG did not affect behaviors not directly related to 
genital reflex function.  For example, there was no change from baseline in the mean 
latency to initiate copulation, or in the mean post-ejaculatory interval within either group 
(Figure 2).  By contrast, serotonergic lesions of the vlPAG facilitated male sexual 
behavior in many measures related to genital reflex functions.  While there was no 
change from baseline in the mean total of mounts or intromissions within either group 
(Figure 3A & B), there was an increase from baseline in the mean number of 
ejaculations within the lesion group (p=0.005) but not the sham group (p=1.000). In 
addition, the mean number of ejaculations in the sexual behavior test was significantly 
greater in the lesion group than in the sham group (p=0.039, Figure 3C).  There was a 
decrease from baseline in the mean number of intromissions required for ejaculation 
within both groups (lesion: p=0.004; sham: p=0.039; Figure 3D).  There was a trend 
approaching statistical significance for a decrease from baseline in the mean ejaculation 
latency within the lesion group (p=0.054; Figure 3E), and this trend is supported by the 
significantly shorter mean ejaculation latency in the sexual behavior test in the lesion 
group versus the sham group (p=0.026; Figure 3E). 
 
4 Discussion 
 Overall, serotonergic lesions of the vlPAG in male rats produced a facilitation of 
sexual behavior.  In particular, 5-HT lesions of the vlPAG significantly increased the 
number of ejaculations during the mating bout, and there was a trend for a decrease in 
the mean latency to ejaculation. 5-HT vlPAG lesioned animals also had significantly 
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shorter ejaculation latencies as compared to sham.  There were no differences in the 
mean latency to mate, or in the post-ejaculatory interval for either group indicating that 
the effect of serotonergic vlPAG lesions is limited to those behaviors directly associated 
with genital reflexes. 
 The facilitation of sexual behavior we observed was specific to those measures 
associated with genital reflex function.  Given the anatomical connections between 
vlPAG 5-HT cells and the nPGi (Bago et al., 2002; Normandin and Murphy, 2008; 
Underwood et al., 1999), as well as the concordance of effects in both vlPAG 5-HT 
lesions and nPGi lesions (Liu and Sachs, 1999; Yells et al., 1992), it is likely that the 
effects observed here are dependent on vlPAG 5-HT neurotransmission to the nPGi.  In 
the context of a normally behaving animal, one would expect that 5-HT from the vlPAG 
serves to enhance nPGi activity, thereby increasing descending inhibition of genital 
reflexes.  This serotonergic signal from the vlPAG would be particularly active in 
behavioral contexts where sexual behavior would not be appropriate (e.g. a “fight-or-
flight” response) and likely “de-activated” when mating conditions were optimal (e.g. 
availability of a sexually receptive conspecific in the absence of a predator).  This 
serotonergic vlPAG-nPGi pathway may effectively act as a gating mechanism for 
descending inhibition of genital reflexes. 
 Regulation of nPGi function (and thereby genital reflexes) through vlPAG is an 
interesting prospect, as midbrain periaqueductal gray (PAG) cells are known to be 
involved in the coordination of cardiovascular responses to anxiety and stress (Johnson 
et al., 2004; Moraes et al., 2008; Murphy et al., 1995), nociception (Haghparast and 
Ahmad-Molaei, 2009; Loyd et al., 2007), as well as social behaviors (Lonstein and 
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Stern, 1998; Pavesi et al., 2007), and could therefore signal the current behavioral 
context to the nPGi. With respect to sexual behavior, we have previously found that the 
medial preoptic area (MPOA) of the hypothalamus, a region critical in the expression of 
male sexual behavior (Arendash and Gorski, 1983; Malsbury, 1971), including genital 
reflexes (Giuliano et al., 1996; Marson and McKenna, 1994), provides input to the nPGi 
both directly (Normandin and Murphy, 2008) and through a PAG relay (Murphy and 
Hoffman, 2001).  This MPOA-PAG pathway may provide necessary input to the nPGi 
regarding sexual “tone.”  Indeed electrolytic lesions of the PAG, including the vlPAG, 
blocks normal MPOA-elicited bulbospongiosus contractions (Marson, 2004), suggesting 
that the MPOA-vlPAG-nPGi circuit is required for the elicitation of genital reflexes. 
 The medially adjacent dorsal raphe nucleus (DR) also contains serotonergic 
neurons that may have been affected by our lesions.  However, results from previous 
work suggest that our observed findings are primarily the result of vlPAG lesions, and 
not due to the spread of the toxin into the DR.  For example, in male rats, lesions of the 
DR, or application of 5-HT or 5-HT agonists to the DR have no effect on male 
ejaculatory behavior (Albinsson et al., 1996; Fernandez-Guasti et al., 1992; Hillegaart, 
1991), although one study has reported that 5-HT DR manipulations shortened both the 
latency to ejaculate and the post-ejaculatory interval (McIntosh and Barfield, 1984).  
Interestingly, lesions of the DR also have been found to facilitate lordosis in male rats 
treated with estradiol (Kakeyama and Yamanouchi, 1992), leading to speculation that 
the DR is not involved in male typical sexual behavior per se, but rather inhibits female-
typical behavior in male rats.   
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5 Conclusions 
 Serotonergic lesions of the vlPAG in male rats facilitated genital reflex function in 
a manner similar to nPGi lesions.  This result lends evidence to the functional 
serotonergic connectivity between the vlPAG and nPGi.  This work has implications for 
the occurrence of SSRI-induced delayed ejaculation in human males, and in particular, 
suggests that these drugs may be producing an effect by increasing serotonergic 
neurotransmission within the vlPAG-nPGi pathway.  Limiting serotonergic drugs for 
mood disorders in humans to receptors and loci that influence mood regulation systems, 
but not sexual behavior systems is an emerging area of research (Baldwin et al., 2006; 
Breuer et al., 2008; Kennedy and Rizvi, 2010).  While it has been known that SSRIs can 
inhibit genital reflexes in male rats at the level of the spinal cord (Marson and McKenna, 
1992), our work implies that this could also occur through the nPGi via vlPAG 5-HT 
input.  Thus, in developing treatments for depression and anxiety, clinicians must 
consider both the spinal and supraspinal targets of serotonergic drugs in this genital 
reflex circuitry.  In addition, SSRIs are often prescribed to men experiencing premature 
ejaculation (Hatzimouratidis et al., 2010; Hellstrom, 2009).  A global increase in 5-HT is 
neither warranted nor desired in these patients, as other side effects may be incurred 
(Haddad and Dursun, 2008; Hellstrom, 2009) as a result of treatment.  Targeting the 
serotonergic vlPAG pathway to the nPGi with appropriately specific drugs may be one 
way to circumvent global treatment of these patients with SSRIs.  However, it remains 
to be elucidated which 5-HT receptor subtypes on nPGi cells are responsible for 
modulating nPGi activity. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
 
 
References 
Ahlenius, S, Larsson, K. Opposite effects of 5-methoxy-N,N-di-methyl-tryptamine and 5-
hydroxytryptophan on male rat sexual behavior. Pharmacol Biochem Behav 
1991;38:201-205. 
Ahlenius, S, Larsson, K, Svensson, L. Further evidence for an inhibitory role of central 
5-HT in male rat sexual behavior. Psychopharmacology (Berl) 1980;68:217-220. 
Albinsson, A, Andersson, G, Andersson, K, Vega-Matuszczyk, J, Larsson, K. The 
effects of lesions in the mesencephalic raphe systems on male rat sexual behavior and 
locomotor activity. Behav Brain Res 1996;80:57-63. 
Arendash, GW, Gorski, RA. Effects of discrete lesions of the sexually dimorphic nucleus 
of the preoptic area or other medial preoptic regions on the sexual behavior of male 
rats. Brain Res Bull 1983;10:147-154. 
Arroll, B, Elley, CR, Fishman, T, Goodyear-Smith, FA, Kenealy, T, Blashki, G, Kerse, N, 
Macgillivray, S. Antidepressants versus placebo for depression in primary care. 
Cochrane Database Syst Rev 2009:CD007954. 
Azmitia, EC, Gannon, PJ. The primate serotonergic system: a review of human and 
animal studies and a report on Macaca fascicularis. Adv Neurol 1986;43:407-468. 
Bago, M, Marson, L, Dean, C. Serotonergic projections to the rostroventrolateral 
medulla from midbrain and raphe nuclei. Brain Res 2002;945:249-258. 
Baldwin, D, Bridgman, K, Buis, C. Resolution of sexual dysfunction during double-blind 
treatment of major depression with reboxetine or paroxetine. J Psychopharmacol 
2006;20:91-96. 
Barfield, MA, Lisk, RD. Advancement of behavioral estrus by subcutaneous injection of 
progesterone in the 4-day cyclic rat. Endocrinology 1970;87:1096-1098. 
Bitran, D, Hull, EM. Pharmacological analysis of male rat sexual behavior. Neurosci 
Biobehav Rev 1987;11:365-389. 
Bjorklund, A, Baumgarten, HG, Rensch, A. 5,7-Dihydroxytryptamine: improvement of its 
selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J 
Neurochem 1975;24:833-835. 
Breuer, ME, Chan, JS, Oosting, RS, Groenink, L, Korte, SM, Campbell, U, Schreiber, R, 
Hanania, T, Snoeren, EM, Waldinger, M, Olivier, B. The triple monoaminergic reuptake 
inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model 
and lacks sexual side effects. Eur Neuropsychopharmacol 2008;18:908-916. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
15 
 
Clement, P, Bernabe, J, Gengo, P, Denys, P, Laurin, M, Alexandre, L, Giuliano, F. 
Supraspinal site of action for the inhibition of ejaculatory reflex by dapoxetine. Eur Urol 
2007;51:825-832. 
de Jong, TR, Pattij, T, Veening, JG, Dederen, PJ, Waldinger, MD, Cools, AR, Olivier, B. 
Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos 
immunoreactivity. Eur J Pharmacol 2005;509:49-59. 
de Jong, TR, Veening, JG, Waldinger, MD, Cools, AR, Olivier, B. Serotonin and the 
neurobiology of the ejaculatory threshold. Neurosci Biobehav Rev 2006;30:893-907. 
Fay, R, Kubin, L. Pontomedullary distribution of 5-HT2A receptor-like protein in the rat. J 
Comp Neurol 2000;418:323-345. 
Fernandez-Guasti, A, Escalante, AL, Ahlenius, S, Hillegaart, V, Larsson, K. Stimulation 
of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual 
behaviour. Eur J Pharmacol 1992;210:121-129. 
Fonseca, MI, Ni, YG, Dunning, DD, Miledi, R. Distribution of serotonin 2A, 2C and 3 
receptor mRNA in spinal cord and medulla oblongata. Brain Res Mol Brain Res 
2001;89:11-19. 
Giuliano, F, Rampin, O, Brown, K, Courtois, F, Benoit, G, Jardin, A. Stimulation of the 
medial preoptic area of the hypothalamus in the rat elicits increases in intracavernous 
pressure. Neurosci Lett 1996;209:1-4. 
Gonzales, G, Mendoza, L, Ruiz, J, Torrejon, J. A demonstration that 5-
hydroxytryptamine administered peripherally can affect sexual behavior in male rats. 
Life Sci 1982;31:2775-2781. 
Haddad, PM, Dursun, SM. Neurological complications of psychiatric drugs: clinical 
features and management. Hum Psychopharmacol 2008;23 Suppl 1:15-26. 
Haghparast, A, Ahmad-Molaei, L. Effects of electrolytic lesion of dorsolateral 
periaqueductal gray on analgesic response of morphine microinjected into the nucleus 
cuneiformis in rat. Neurosci Lett 2009;451:165-169. 
Hatzimouratidis, K, Amar, E, Eardley, I, Giuliano, F, Hatzichristou, D, Montorsi, F, Vardi, 
Y, Wespes, E. Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and 
Premature Ejaculation. Eur Urol 2010. 
Hellstrom, WJ. Emerging treatments for premature ejaculation: focus on dapoxetine. 
Neuropsychiatr Dis Treat 2009;5:37-46. 
Hermann, GE, Holmes, GM, Rogers, RC, Beattie, MS, Bresnahan, JC. Descending 
spinal projections from the rostral gigantocellular reticular nuclei complex. J Comp 
Neurol 2003;455:210-221. 
Hiemke, C, Hartter, S. Pharmacokinetics of selective serotonin reuptake inhibitors. 
Pharmacol Ther 2000;85:11-28. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
16 
 
Hillegaart, V. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and 
median raphe nuclei on core temperature in the rat. Psychopharmacology (Berl) 
1991;103:291-296. 
Hoffman, BJ, Mezey, E. Distribution of serotonin 5-HT1C receptor mRNA in adult rat 
brain. FEBS Lett 1989;247:453-462. 
Hsu, GL, Hsieh, CH, Wen, HS, Hsu, WL, Wu, CH, Fong, TH, Chen, SC, Tseng, GF. 
Anatomy of the human penis: the relationship of the architecture between skeletal and 
smooth muscles. J Androl 2004;25:426-431. 
Hsu, JH, Shen, WW. Male sexual side effects associated with antidepressants: a 
descriptive clinical study of 32 patients. Int J Psychiatry Med 1995;25:191-201. 
Johnson, PL, Lightman, SL, Lowry, CA. A functional subset of serotonergic neurons in 
the rat ventrolateral periaqueductal gray implicated in the inhibition of 
sympathoexcitation and panic. Ann N Y Acad Sci 2004;1018:58-64. 
Johnson, RD. Descending pathways modulating the spinal circuitry for ejaculation: 
effects of chronic spinal cord injury. Prog Brain Res 2006;152:415-426. 
Kakeyama, M, Yamanouchi, K. Lordosis in male rats: the facilitatory effect of 
mesencephalic dorsal raphe nucleus lesion. Physiol Behav 1992;51:181-184. 
Kennedy, SH, Rizvi, S. Sexual dysfunction, depression, and the impact of 
antidepressants. J Clin Psychopharmacol 2009;29:157-164. 
Kennedy, SH, Rizvi, SJ. Agomelatine in the Treatment of Major Depressive Disorder: 
Potential for Clinical Effectiveness. CNS Drugs 2010. 
Koenig, AM, Thase, ME. First-line pharmacotherapies for depression - what is the best 
choice? Pol Arch Med Wewn 2009;119:478-486. 
Liu, YC, Sachs, BD. Erectile function in male rats after lesions in the lateral 
paragigantocellular nucleus. Neurosci Lett 1999;262:203-206. 
Lonstein, JS, Stern, JM. Site and behavioral specificity of periaqueductal gray lesions 
on postpartum sexual, maternal, and aggressive behaviors in rats. Brain Res 
1998;804:21-35. 
Loyd, DR, Morgan, MM, Murphy, AZ. Morphine preferentially activates the 
periaqueductal gray-rostral ventromedial medullary pathway in the male rat: a potential 
mechanism for sex differences in antinociception. Neuroscience 2007;147:456-468. 
Loyd, DR, Murphy, AZ. Sex differences in the anatomical and functional organization of 
the periaqueductal gray-rostral ventromedial medullary pathway in the rat: a potential 
circuit mediating the sexually dimorphic actions of morphine. J Comp Neurol 
2006;496:723-738. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
17 
 
Malsbury, CW. Facilitation of male rat copulatory behavior by electrical stimulation of 
the medial preoptic area. Physiol Behav 1971;7:797-805. 
Marson, L. Lesions of the periaqueductal gray block the medial preoptic area-induced 
activation of the urethrogenital reflex in male rats. Neurosci Lett 2004;367:278-282. 
Marson, L, Carson 3rd, CC. Central Nervous System Innervation of the Penis, Prostate, 
and Perineal Muscles: A Transneuronal Tracing Study. Mol Urol 1999;3:43-50. 
Marson, L, McKenna, KE. CNS cell groups involved in the control of the 
ischiocavernosus and bulbospongiosus muscles: a transneuronal tracing study using 
pseudorabies virus. J Comp Neurol 1996;374:161-179. 
Marson, L, McKenna, KE. The identification of a brainstem site controlling spinal sexual 
reflexes in male rats. Brain Res 1990;515:303-308. 
Marson, L, McKenna, KE. A role for 5-hydroxytryptamine in descending inhibition of 
spinal sexual reflexes. Exp Brain Res 1992;88:313-320. 
Marson, L, McKenna, KE. Stimulation of the hypothalamus initiates the urethrogenital 
reflex in male rats. Brain Res 1994;638:103-108. 
McEwen, BS, Jones, KJ, Pfaff, DW. Hormonal control of sexual behavior in the female 
rat: molecular, cellular and neurochemical studies. Biol Reprod 1987;36:37-45. 
McIntosh, TK, Barfield, RJ. Brain monoaminergic control of male reproductive behavior. 
I. Serotonin and the post-ejaculatory refractory period. Behav Brain Res 1984;12:255-
265. 
Miura, T, Kondo, Y, Akimoto, M, Sakuma, Y. Electromyography of male rat perineal 
musculature during copulatory behavior. Urol Int 2001;67:240-245. 
Moraes, CL, Bertoglio, LJ, Carobrez, AP. Interplay between glutamate and serotonin 
within the dorsal periaqueductal gray modulates anxiety-related behavior of rats 
exposed to the elevated plus-maze. Behav Brain Res 2008;194:181-186. 
Mos, J, Mollet, I, Tolboom, JT, Waldinger, MD, Olivier, B. A comparison of the effects of 
different serotonin reuptake blockers on sexual behaviour of the male rat. Eur 
Neuropsychopharmacol 1999;9:123-135. 
Murphy, AZ, Ennis, M, Rizvi, TA, Behbehani, MM, Shipley, MT. Fos expression induced 
by changes in arterial pressure is localized in distinct, longitudinally organized columns 
of neurons in the rat midbrain periaqueductal gray. J Comp Neurol 1995;360:286-300. 
Murphy, AZ, Hoffman, GE. Distribution of gonadal steroid receptor-containing neurons 
in the preoptic-periaqueductal gray-brainstem pathway: a potential circuit for the 
initiation of male sexual behavior. J Comp Neurol 2001;438:191-212. 
Murphy, AZ, Rizvi, TA, Ennis, M, Shipley, MT. The organization of preoptic-medullary 
circuits in the male rat: evidence for interconnectivity of neural structures involved in 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
18 
 
reproductive behavior, antinociception and cardiovascular regulation. Neuroscience 
1999;91:1103-1116. 
Normandin, JJ, Murphy, AZ. Excitotoxic lesions of the nucleus paragigantocellularis 
facilitate male sexual behavior but attenuate female sexual behavior in rats. 
Neuroscience 2010;In press. 
Normandin, JJ, Murphy, AZ. Nucleus paragigantocellularis afferents in male and female 
rats: organization, gonadal steroid receptor expression, and activation during sexual 
behavior. J Comp Neurol 2008;508:771-794. 
Pavesi, E, Enck, MC, De Toledo, CA, Terenzi, MG. Disruption of maternal behaviour by 
acute conspecific interaction induces selective activation of the lateral periaqueductal 
grey. Eur J Neurosci 2007;26:2055-2065. 
Paxinos, G, Watson, C. The rat brain in stereotaxic coordinates. Amsterdam ; Boston: 
Elsevier Academic Press, 2005. 
Pescatori, ES, Calabro, A, Artibani, W, Pagano, F, Triban, C, Italiano, G. Electrical 
stimulation of the dorsal nerve of the penis evokes reflex tonic erections of the penile 
body and reflex ejaculatory responses in the spinal rat. J Urol 1993;149:627-632. 
Quadagno, DM, McCullough, J, Langan, R. The effect of varying amounts of exogenous 
estradiol benzoate on estrous behavior in the rat. Horm Behav 1972;3:175-179. 
Richelson, E. The pharmacology of antidepressants at the synapse: focus on newer 
compounds. J Clin Psychiatry 1994;55 Suppl A:34-39; discussion 40-31, 98-100. 
Schweitzer, I, Maguire, K, Ng, C. Sexual side-effects of contemporary antidepressants: 
review. Aust N Z J Psychiatry 2009;43:795-808. 
Shafik, A, Shafik, AA, El Sibai, O, Shafik, IA. Electromyographic study of ejaculatory 
mechanism. Int J Androl 2009;32:212-217. 
Tang, Y, Rampin, O, Giuliano, F, Ugolini, G. Spinal and brain circuits to motoneurons of 
the bulbospongiosus muscle: retrograde transneuronal tracing with rabies virus. J Comp 
Neurol 1999;414:167-192. 
Thor, KB, Blitz-Siebert, A, Helke, CJ. Autoradiographic localization of 5HT1 binding 
sites in the medulla oblongata of the rat. Synapse 1992;10:185-205. 
Thor, KB, Blitz-Siebert, A, Helke, CJ. Discrete localization of high-density 5-HT1A 
binding sites in the midline raphe and parapyramidal region of the ventral medulla 
oblongata of the rat. Neurosci Lett 1990;108:249-254. 
Underwood, MD, Arango, V, Bakalian, MJ, Ruggiero, DA, Mann, JJ. Dorsal raphe 
nucleus serotonergic neurons innervate the rostral ventrolateral medulla in rat. Brain 
Res 1999;824:45-55. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
19 
 
Vega Matuszcyk, J, Larsson, K, Eriksson, E. The selective serotonin reuptake inhibitor 
fluoxetine reduces sexual motivation in male rats. Pharmacol Biochem Behav 
1998;60:527-532. 
Watson, RE, Jr., Wiegand, SJ, Clough, RW, Hoffman, GE. Use of cryoprotectant to 
maintain long-term peptide immunoreactivity and tissue morphology. Peptides 
1986;7:155-159. 
Yells, DP, Hendricks, SE, Prendergast, MA. Lesions of the nucleus 
paragigantocellularis: effects on mating behavior in male rats. Brain Res 1992;596:73-
79. 
Yells, DP, Prendergast, MA, Hendricks, SE, Nakamura, M. Fluoxetine-induced inhibition 
of male rat copulatory behavior: modification by lesions of the nucleus 
paragigantocellularis. Pharmacol Biochem Behav 1994;49:121-127. 
Zec, N, Kinney, HC. Anatomic relationships of the human nucleus paragigantocellularis 
lateralis: a DiI labeling study. Auton Neurosci 2001;89:110-124. 
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
20 
 
 
Figure 1 - Photomicrograph of sham lesion and lesion sites 
A photomicrograph of 5-hydroxytryptophan (5-HTP) immunolabeled cells of the 
ventrolateral periaqueductal gray (vlPAG) and dorsal raphe (DR) is shown on the left, 
with a diagram (modified from Paxinos and Watson, 2005) at the approximate level of 
the tissue section shown on the right.  Intra-vlPAG injection of vehicle (photomicrograph 
left) preserved 5-HTP immunoreactivity in the vlPAG.  Intra-vlPAG injection of 5,7-
dihydroxytryptamine (photomicrograph right) markedly reduced immunoreactivity for 5-
HTP in the vlPAG.  Lesion sites are indicating by the gray circles in the diagram.  
Aq=cerebral aqueduct. 
  
Figure 2 - Measures of sexual behavior unrelated to genital reflex function 
Serotonergic lesions of the vlPAG did not alter the latency to mating (A) or post-
ejaculatory interval (B) from baseline to sexual behavior test within either the sham or 
lesion groups.  Error bars = standard error of the mean (SEM). 
 
Figure 3 - Measures of sexual behaviors related to genital reflex function 
Serotonergic lesions of the vlPAG did not alter the mean number of mounts (A) or 
intromissions (B) from baseline to sexual behavior test within either group.  However, 
such lesions significantly increased the mean number of ejaculations (C) within the 
lesion group, which was significantly greater than in sham group.  The mean number of 
intromission per ejaculation (D) significantly decreased within both the sham and lesion 
group.  The mean ejaculation latency (min.; E) decreased within the lesion group, 
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approaching significance, which was significantly less than the sham group.  * = p<0.05, 
error bars = SEM. 
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